🚨 **BIG WIN FOR PEPTIDE SCIENCE!** 🎉
The FDA's Pharmacy Compounding Advisory Committee has released its initial recommendations—and **6 peptides received favorable votes.**
âś… BPC-157
âś… Epitalon
âś… KPV
âś… MOTS-c
âś… Semax
âś… TB-500
❌ Emideltide (Delta Sleep-Inducing Peptide)
This is a significant moment for the peptide industry and another sign that peptide therapeutics are gaining meaningful regulatory attention.
While these recommendations are **preliminary and non-binding**, they're an exciting step toward the FDA's final guidance in the months ahead.
At Vector Science & Therapeutics, we're excited about the future and remain focused on advancing **pharmaceutical-grade peptide manufacturing** and **next-generation targeted drug delivery technologies.**
The momentum is real. 🚀
#Peptides #Biotech #RegenerativeMedicine #PrecisionMedicine #DrugDelivery #HealthcareInnovation #FDA #TSXV #PAIN
The FDA's Pharmacy Compounding Advisory Committee has released its initial recommendations—and **6 peptides received favorable votes.**
âś… BPC-157
âś… Epitalon
âś… KPV
âś… MOTS-c
âś… Semax
âś… TB-500
❌ Emideltide (Delta Sleep-Inducing Peptide)
This is a significant moment for the peptide industry and another sign that peptide therapeutics are gaining meaningful regulatory attention.
While these recommendations are **preliminary and non-binding**, they're an exciting step toward the FDA's final guidance in the months ahead.
At Vector Science & Therapeutics, we're excited about the future and remain focused on advancing **pharmaceutical-grade peptide manufacturing** and **next-generation targeted drug delivery technologies.**
The momentum is real. 🚀
#Peptides #Biotech #RegenerativeMedicine #PrecisionMedicine #DrugDelivery #HealthcareInnovation #FDA #TSXV #PAIN